Skip to main content
. Author manuscript; available in PMC: 2022 Jul 15.
Published in final edited form as: Open J Immunol. 2018 Jun 29;8(2):36–80. doi: 10.4236/oji.2018.82004

Figure 7.

Figure 7.

Pro-tumor cell polarization at the start of treatment requires increased doses of M1 Macrophages and Fresolimumab to eliminate a tumor.